Literature DB >> 12885886

Newcastle disease virus V protein is associated with viral pathogenesis and functions as an alpha interferon antagonist.

Zhuhui Huang1, Sateesh Krishnamurthy, Aruna Panda, Siba K Samal.   

Abstract

Newcastle disease virus (NDV) edits its P gene by inserting one or two G residues at the conserved editing site (UUUUUCCC, genome sense) and transcribes the P mRNA (unedited), the V mRNA (with a +1 frameshift), and the W mRNA (with a +2 frameshift). All three proteins are amino coterminal but vary at their carboxyl terminus in length and amino acid composition. Little is known about the role of the V and W proteins in NDV replication and pathogenesis. We have constructed and recovered two recombinant viruses in which the expression of the V or both the V and W proteins has been abolished. Compared to the parental virus, the mutant viruses showed impaired growth in cell cultures, except in Vero cells. However, transient expression of the carboxyl-terminal portion of the V protein enhanced the growth of the mutant viruses. In embryonated chicken eggs, the parental virus grew to high titers in embryos of different gestational ages, whereas the mutant viruses showed an age-dependent phenomenon, growing to lower titer in more-developed embryos. An interferon (IFN) sensitivity assay showed that the parental virus was more resistant to the antiviral effect of IFN than the mutant viruses. Moreover, infection with the parental virus resulted in STAT1 protein degradation, but not with the mutant viruses. These findings indicate that the V protein of NDV possesses the ability to inhibit alpha IFN and that the IFN inhibitory function lies in the carboxyl-terminal domain. Pathogenicity studies showed that the V protein of NDV significantly contributes to the virus virulence.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12885886      PMCID: PMC167241          DOI: 10.1128/jvi.77.16.8676-8685.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  52 in total

1.  Recovery of a virulent strain of newcastle disease virus from cloned cDNA: expression of a foreign gene results in growth retardation and attenuation.

Authors:  S Krishnamurthy; Z Huang; S K Samal
Journal:  Virology       Date:  2000-12-05       Impact factor: 3.616

Review 2.  Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures.

Authors:  S Goodbourn; L Didcock; R E Randall
Journal:  J Gen Virol       Date:  2000-10       Impact factor: 3.891

3.  The Ebola virus VP35 protein functions as a type I IFN antagonist.

Authors:  C F Basler; X Wang; E Mühlberger; V Volchkov; J Paragas; H D Klenk; A García-Sastre; P Palese
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

4.  C terminal CYS-RICH region of mumps virus structural V protein correlates with block of interferon alpha and gamma signal transduction pathway through decrease of STAT 1-alpha.

Authors:  T Kubota; N Yokosawa; S Yokota ; N Fujii
Journal:  Biochem Biophys Res Commun       Date:  2001-04-27       Impact factor: 3.575

5.  Single amino acid substitution in the V protein of simian virus 5 differentiates its ability to block interferon signaling in human and murine cells.

Authors:  D F Young; N Chatziandreou; B He; S Goodbourn; R A Lamb; R E Randall
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

6.  Evasion of host defenses by measles virus: wild-type measles virus infection interferes with induction of Alpha/Beta interferon production.

Authors:  D Naniche; A Yeh; D Eto; M Manchester; R M Friedman; M B Oldstone
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

7.  Newcastle disease virus phosphoprotein gene analysis and transcriptional editing in avian cells.

Authors:  D P Locke; H S Sellers; J M Crawford; S Schultz-Cherry; D J King; R J Meinersmann; B S Seal
Journal:  Virus Res       Date:  2000-08       Impact factor: 3.303

8.  A recombinant newcastle disease virus with low-level V protein expression is immunogenic and lacks pathogenicity for chicken embryos.

Authors:  T Mebatsion; S Verstegen; L T De Vaan; A Römer-Oberdörfer; C C Schrier
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

9.  The V protein of human parainfluenza virus 2 antagonizes type I interferon responses by destabilizing signal transducer and activator of transcription 2.

Authors:  J P Parisien; J F Lau; J J Rodriguez; B M Sullivan; A Moscona; G D Parks; R A Lamb; C M Horvath
Journal:  Virology       Date:  2001-05-10       Impact factor: 3.616

10.  Recombinant measles viruses with mutations in the C, V, or F gene have altered growth phenotypes in vivo.

Authors:  A Valsamakis; H Schneider; P G Auwaerter; H Kaneshima; M A Billeter; D E Griffin
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

View more
  84 in total

1.  Newcastle disease virus-vectored rabies vaccine is safe, highly immunogenic, and provides long-lasting protection in dogs and cats.

Authors:  Jinying Ge; Xijun Wang; Lihong Tao; Zhiyuan Wen; Na Feng; Songtao Yang; Xianzhu Xia; Chinglai Yang; Hualan Chen; Zhigao Bu
Journal:  J Virol       Date:  2011-06-01       Impact factor: 5.103

2.  Nipah virus V and W proteins have a common STAT1-binding domain yet inhibit STAT1 activation from the cytoplasmic and nuclear compartments, respectively.

Authors:  Megan L Shaw; Adolfo García-Sastre; Peter Palese; Christopher F Basler
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

3.  Activation of the extracellular signal-regulated kinase pathway is required for replication of Newcastle disease virus.

Authors:  Jie Ni; Shunlin Hu; Xiaoquan Wang; Xiaowen Liu; Zenglei Hu; Xiufan Liu
Journal:  Arch Virol       Date:  2021-01-24       Impact factor: 2.574

Review 4.  Paramyxovirus evasion of innate immunity: Diverse strategies for common targets.

Authors:  Michelle D Audsley; Gregory W Moseley
Journal:  World J Virol       Date:  2013-05-12

5.  Evaluation of humoral, mucosal, and cellular immune responses following co-immunization of HIV-1 Gag and Env proteins expressed by Newcastle disease virus.

Authors:  Sunil K Khattar; Senthilkumar Palaniyandi; Sweety Samal; Celia C LaBranche; David C Montefiori; Xiaoping Zhu; Siba K Samal
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

6.  A Novel Chimeric Oncolytic Virus Vector for Improved Safety and Efficacy as a Platform for the Treatment of Hepatocellular Carcinoma.

Authors:  Sarah Abdullahi; Melanie Jäkel; Sabine J Behrend; Katja Steiger; Geoffrey Topping; Teresa Krabbe; Alessio Colombo; Volker Sandig; Tobias S Schiergens; Wolfgang E Thasler; Jens Werner; Stefan F Lichtenthaler; Roland M Schmid; Oliver Ebert; Jennifer Altomonte
Journal:  J Virol       Date:  2018-11-12       Impact factor: 5.103

7.  A recombinant Newcastle disease virus (NDV) expressing VP2 protein of infectious bursal disease virus (IBDV) protects against NDV and IBDV.

Authors:  Zhuhui Huang; Subbiah Elankumaran; Abdul S Yunus; Siba K Samal
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

8.  The interferon antagonistic activities of the V proteins of NDV correlated with their virulence.

Authors:  Xinglong Wang; Ruiyi Dang; Zengqi Yang
Journal:  Virus Genes       Date:  2019-01-31       Impact factor: 2.332

9.  Production of Newcastle disease virus by Vero cells grown on cytodex 1 microcarriers in a 2-litre stirred tank bioreactor.

Authors:  Mohd Azmir Arifin; Maizirwan Mel; Mohamed Ismail Abdul Karim; Aini Ideris
Journal:  J Biomed Biotechnol       Date:  2010-06-10

10.  New World hantaviruses activate IFNlambda production in type I IFN-deficient vero E6 cells.

Authors:  Joseph Prescott; Pamela Hall; Mariana Acuna-Retamar; Chunyan Ye; Marc G Wathelet; Hideki Ebihara; Heinz Feldmann; Brian Hjelle
Journal:  PLoS One       Date:  2010-06-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.